Cargando…
Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited
Silexan is a proprietary active substance produced from Lavandula angustifolia, with proven anxiolytic efficacy in subthreshold and generalized anxiety disorder as well as in mixed anxiety and depressive disorder with beneficial impact on anxiety-related sleep disturbances. The pharmacological profi...
Autores principales: | Bartova, Lucie, Dold, Markus, Volz, Hans-Peter, Seifritz, Erich, Möller, Hans-Jürgen, Kasper, Siegfried |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958187/ https://www.ncbi.nlm.nih.gov/pubmed/35262795 http://dx.doi.org/10.1007/s00406-022-01390-z |
Ejemplares similares
-
Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials
por: Dold, Markus, et al.
Publicado: (2023) -
Efficacy of Silexan in subthreshold anxiety: meta-analysis of randomised, placebo-controlled trials
por: Möller, Hans-Jürgen, et al.
Publicado: (2017) -
Silexan for treatment of anxiety and depression in the context of COVID-19
por: Bartova, Lucie, et al.
Publicado: (2023) -
No Abuse Potential of Silexan in Healthy Recreational Drug Users: A Randomized Controlled Trial
por: Seifritz, Erich, et al.
Publicado: (2020) -
Therapeutic effects of Silexan on somatic symptoms and physical health in patients with anxiety disorders: A meta‐analysis
por: von Känel, Roland, et al.
Publicado: (2021)